Kamada Ltd. (TLV:KMDA)
2,342.00
-25.00 (-1.06%)
Sep 4, 2025, 4:36 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.35 billion as of September 4, 2025. Its market cap has increased by 12.64% in one year.
Market Cap
1.35B
Enterprise Value
1.17B
Revenue
571.15M
Ranking
n/a
PE Ratio
21.76
Stock Price
2,342.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.35B, an increase of 1,504.94%. That is a compound annual growth rate of 14.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 4, 2025 | 1.35B | 6.50% |
Dec 31, 2024 | 1.27B | -0.69% |
Dec 31, 2023 | 1.28B | 108.12% |
Dec 29, 2022 | 615.02M | -33.18% |
Dec 30, 2021 | 920.36M | -0.46% |
Dec 31, 2020 | 924.59M | -3.70% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 72.27B |
Danel (Adir Yeoshua) | 2.84B |
Bait Bakfar | 1.02B |
BrainsWay | 990.83M |
SofWave Medical | 965.04M |
Novolog (Pharm-Up 1966) | 781.64M |
Ilex Medical | 672.63M |
Bonus BioGroup | 303.66M |